Target Name: OR52M1
NCBI ID: G119772
Review Report on OR52M1 Target / Biomarker Content of Review Report on OR52M1 Target / Biomarker
OR52M1
Other Name(s): OR11-11 | OR52M1P | olfactory receptor family 52 subfamily M member 1 | olfactory receptor, family 52, subfamily M, member 1 pseudogene | olfactory receptor, family 52, subfamily M, member 3 pseudogene | Olfactory receptor 52M1 | Olfactory receptor, family 52, subfamily M, member 1 pseudogene | Olfactory receptor family 52 subfamily M member 1 | olfactory receptor OR11-11 | O52M1_HUMAN | Olfactory receptor OR11-11 | OR52M3P | Olfactory receptor, family 52, subfamily M, member 3 pseudogene

OR52M1: A Drug Target / Disease Biomarker

OR52M1, also known as interleukin-1尾 (IL-1尾), is a protein that is expressed in various tissues throughout the body, including the immune system, skin, and tissues. OR52M1 has been identified as a potential drug target and has been shown to play a role in a variety of biological processes, including inflammation, pain, and cancer.

OR52M1 is a member of the IL-1 family, which includes several cytokines that play a crucial role in the immune system. IL-1尾 is a potent cytokine that is involved in the recruitment and activation of immune cells, including T cells, which are responsible for cell-mediated immunity. OR52M1 has been shown to promote the production of IL-1尾 by immune cells and has been linked to the development of various diseases, including autoimmune disorders and cancer.

One of the key functions of OR52M1 is its role in the regulation of pain. OR52M1 has been shown to contribute to the development and progression of pain conditions, including neuropathic pain and chronic pain. OR52M1 has also been shown to interact with other pain molecules, including nociceptins, which are involved in pain signaling.

OR52M1 has also been shown to be involved in the regulation of inflammation. OR52M1 has been shown to contribute to the production and recruitment of immune cells, including neutrophils, which are involved in the regulation of inflammation. OR52M1 has also been shown to interact with other inflammation molecules, including nuclear factor kappa B (NF-kappa-B), which is involved in the regulation of inflammation.

In addition to its role in pain and inflammation, OR52M1 has also been shown to be involved in the regulation of cell growth and differentiation. OR52M1 has been shown to contribute to the production and maintenance of stem cells, which are involved in the regulation of cell growth and differentiation. OR52M1 has also been shown to interact with other molecules involved in cell growth and differentiation, including TGF-β1.

OR52M1 has also been shown to be involved in the regulation of cell survival. OR52M1 has been shown to contribute to the production and maintenance of cancer cells, which are involved in the regulation of cell survival. OR52M1 has also been shown to interact with other molecules involved in cell survival, including the transcription factor p53.

Due to its involvement in a variety of biological processes, OR52M1 has been identified as a potential drug target. Several studies have shown that inhibiting OR52M1 activity can have beneficial effects on a variety of biological processes, including pain, inflammation, and cancer. For example, studies have shown that inhibiting OR52M1 activity can alleviate pain in neuropathic pain models and reduce inflammation in animal models of cancer.

In conclusion, OR52M1 is a protein that is involved in a variety of biological processes throughout the body. OR52M1 has been shown to contribute to the regulation of pain, inflammation, cell growth and differentiation, and cell survival. As a potential drug target, OR52M1 is a promising target for the development of new therapies for a variety of diseases. Further research is needed to fully understand the role of OR52M1 in biological processes and to develop effective therapies.

Protein Name: Olfactory Receptor Family 52 Subfamily M Member 1

Functions: Odorant receptor

The "OR52M1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR52M1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2